GlassScriptPhysician profile
Debra M Epstein
NPI 1821060005
$3,458.48
in general payments reported to CMS, 2019-2025
23 companies · $651 in 2025
The $651 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $655 · 2020: $246 · 2021: $273 · 2022: $645 · 2023: $569 · 2024: $420 · 2025: $651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,527 · Education: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,527.02 |
| Education | $112.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $1,028.85 | 2021-2025 | |
| Abbvie INC. | $700.56 | 2019-2024 | |
| Astellas Pharma US INC | $391.79 | 2019-2025 | Veozah |
| Amgen INC. | $381.37 | 2019-2024 | Prolia, Evenity |
| Amag Pharmaceuticals, INC. | $126.15 | 2019 | |
| Sumitomo Pharma America, INC. | $125.02 | 2023-2025 | Gemtesa, Myfembree |
| Radius Health, INC. | $104.32 | 2019-2024 | |
| Millicent US INC | $86.63 | 2019-2025 | Femring, Intrarosa |
| Avion Pharmaceuticals | $82.44 | 2020-2022 | |
| Evofem Biosciences, INC. | $79.30 | 2021-2024 | Phexxi |
| Exeltis, USA INC. | $72.39 | 2020-2024 | Slynd |
| Therapeuticsmd, INC. | $57.99 | 2019-2021 | |
| Vertical Pharmaceuticals, LLC | $39.71 | 2019 | |
| Hologic Sales and Service, LLC | $37.19 | 2020-2025 | Aptima |
| Mylan Pharmaceuticals INC. | $36.58 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $18.16 | 2019 | |
| Exact Sciences Corporation | $14.69 | 2025 | Cologuard Collection Kit |
| Lupin INC. | $14.66 | 2019 | |
| Merck Sharp & Dohme LLC | $13.11 | 2020 | |
| Organon LLC | $12.51 | 2021 | |
| Coopersurgical, INC. | $12.01 | 2021 | |
| Allergan, INC. | $11.91 | 2020 | |
| Mission Pharmacal Company | $11.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Epstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.